{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:41:44Z","timestamp":1791686504032,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.tiv.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,5,27]],"date-time":"2012-05-27T05:15:16Z","timestamp":1338095716000},"page":"1278-1285","source":"Crossref","is-referenced-by-count":175,"title":["Optimization of the HepaRG cell model for drug metabolism and toxicity studies"],"prefix":"10.1016","volume":"26","author":[{"given":"S\u00e9bastien","family":"Anth\u00e9rieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chesn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Guguen-Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2012.05.008_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CCM.0B013E31816532BE","article-title":"Catecholamines induce an inflammatory response in human hepatocytes","volume":"36","author":"Aninat","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tiv.2012.05.008_b0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/dmd.109.030197","article-title":"Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells","volume":"38","author":"Antherieu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0020","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells","volume":"53","author":"Antherieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0025","first-page":"1052","article-title":"Drug-induced hepatotoxicity. The 13th updated edition of the bibliographic database of drug-related liver injuries and responsible drugs","volume":"24","author":"Biour","year":"2000","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.tiv.2012.05.008_b0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1139\/y87-062","article-title":"Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues","volume":"65","author":"Brien","year":"1987","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.21536","article-title":"Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor","volume":"45","author":"Cerec","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/dmd.110.037721","article-title":"Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor","volume":"39","author":"Darnell","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cbi.2009.07.019","article-title":"Cytometric analysis for drug-induced steatosis in HepG2 cells","volume":"181","author":"Donato","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2012.05.008_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.taap.2010.08.027","article-title":"Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines","volume":"249","author":"Dumont","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2010.03.008","article-title":"Differential toxicity of heterocyclic aromatic amines and their mixture in metabolically competent HepaRG cells","volume":"245","author":"Dumont","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0060","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0065","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.1840080513","article-title":"Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic","volume":"8","author":"Freneaux","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1989.tb03516.x","article-title":"The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction","volume":"28","author":"Ged","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0075","doi-asserted-by":"crossref","first-page":"49220","DOI":"10.1074\/jbc.M207325200","article-title":"Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1\/JNK pathway via glutathione S-transferase regulation","volume":"277","author":"Gilot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2012.05.008_b0080","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2012.05.008_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2012.05.008_b0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tox.2009.09.019","article-title":"Stem cell-derived hepatocytes and their use in toxicology","volume":"270","author":"Guguen-Guillouzo","year":"2010","journal-title":"Toxicology"},{"issue":"Suppl 2","key":"10.1016\/j.tiv.2012.05.008_b0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.98106511","article-title":"Liver cell models in in vitro toxicology","volume":"106","author":"Guillouzo","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2012.05.008_b0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2012.05.008_b0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2012.05.008_b0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","article-title":"A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues","volume":"38","author":"Hart","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0115","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","article-title":"The HepaRG cell line is suitable for bioartificial liver application","volume":"43","author":"Hoekstra","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tiv.2012.05.008_b0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/toxsci\/kfq026","article-title":"Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification","volume":"115","author":"Jennen","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2012.05.008_b0125","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/dmd.107.019901","article-title":"Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies","volume":"36","author":"Josse","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.taap.2011.10.019","article-title":"Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds","volume":"258","author":"Josse","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/mutage\/ger076","article-title":"An adaptation of the human HepaRG cells to the in vitro micronucleus assay","volume":"27","author":"Josse","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tiv.2012.05.008_b0140","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00498250903184018","article-title":"In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells","volume":"39","author":"Kaneko","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2012.05.008_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/187231208785425845","article-title":"Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry","volume":"2","author":"Lahoz","year":"2008","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.tiv.2012.05.008_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2008.11.008","article-title":"Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells","volume":"234","author":"Lambert","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0024-3205(87)90037-3","article-title":"Species differences in metabolism of ketotifen in rat, rabbit and man: demonstration of similar pathways in vivo and in cultured hepatocytes","volume":"40","author":"Le Bigot","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2012.05.008_b0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2012.05.008_b0175","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.ejca.2009.07.010","article-title":"Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression","volume":"45","author":"Legendre","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tiv.2012.05.008_b0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/mutage\/geq039","article-title":"Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays","volume":"25","author":"Le Hegarat","year":"2010","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tiv.2012.05.008_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Le Vee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2012.05.008_b0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro","volume":"63","author":"Lubberstedt","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2012.05.008_b0195","first-page":"185","article-title":"Drug-induced phospholipidosis II. Tissue distribution of the amphiphilic drug chlorphentermine","volume":"4","author":"Lullmann","year":"1975","journal-title":"CRC Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2012.05.008_b0200","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1124\/dmd.110.036848","article-title":"CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload","volume":"39","author":"Madec","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0205","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","article-title":"HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity","volume":"53","author":"McGill","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0210","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1124\/dmd.109.026526","article-title":"Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells","volume":"37","author":"McGinnity","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbi.2010.01.008","article-title":"Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile","volume":"184","author":"Moya","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2012.05.008_b0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0225","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2012.05.008_b0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.pharmtox.45.120403.100058","article-title":"The role of metabolic activation in drug-induced hepatotoxicity","volume":"45","author":"Park","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tiv.2012.05.008_b0235","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2011.04.018","article-title":"Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye","volume":"254","author":"Pernelle","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2012.05.008_b0240","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.tiv.2007.12.004","article-title":"Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes","volume":"22","author":"Petit","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2012.05.008_b0245","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0016-5085(24)05145-X","article-title":"Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies","volume":"86","author":"Poucell","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2012.05.008_b0250","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tiv.2012.05.008_b0255","doi-asserted-by":"crossref","first-page":"e18816","DOI":"10.1371\/journal.pone.0018816","article-title":"Comparative gene expression profiles induced by PPARgamma and PPARalpha\/gamma agonists in human hepatocytes","volume":"6","author":"Rogue","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2012.05.008_b0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/dmd.111.042028","article-title":"Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells","volume":"40","author":"Rogue","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2012.05.008_b0265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.7326\/0003-4819-101-4-462","article-title":"Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity","volume":"101","author":"Rotmensch","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tiv.2012.05.008_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00223481","article-title":"Amiodarone\u2013an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine","volume":"76","author":"Shaikh","year":"1987","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tiv.2012.05.008_b0275","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tiv.2009.03.008","article-title":"Functional expression, inhibition and induction of CYP enzymes in HepaRG cells","volume":"23","author":"Turpeinen","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2012.05.008_b0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejps.2004.10.006","article-title":"Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay","volume":"24","author":"Turpeinen","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2012.05.008_b0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/tx700186p","article-title":"Idiosyncratic drug reactions: past, present, and future","volume":"21","author":"Uetrecht","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2012.05.008_b0290","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jama.1964.03070050023005","article-title":"Tetracycline toxicity in pregnancy. Liver and pancreatic dysfunction","volume":"189","author":"Whalley","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.tiv.2012.05.008_b0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/dmd.111.042309","article-title":"Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs","volume":"40","author":"Zanelli","year":"2012","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233312001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233312001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:41:00Z","timestamp":1743187260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233312001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0887233312001415"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2012.05.008","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}